Tirzepatide 60mg

Tirzepatide is a synthetic dual agonist peptide that simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It represents a novel mechanism of incretin-based research, combining two distinct hormonal pathways in a single molecule.

Research Applications: As a dual incretin receptor agonist, tirzepatide is studied extensively in metabolic research. Clinical and preclinical investigations have examined its effects on glycemic control, body weight reduction, insulin sensitivity, and cardiovascular risk factors. Research has demonstrated significant reductions in HbA1c and body weight in diabetic models.

Key Research Areas:

• Type 2 diabetes and glycemic regulation
• Obesity and body composition research
• Cardiovascular metabolic risk factors
• Insulin sensitivity and beta-cell function
• Dual GIP/GLP-1 receptor pharmacology

For research purposes only. Not for human or veterinary use. Store lyophilized vials at -20°C. After reconstitution with BAC water, refrigerate and use within 4–6 weeks.